Jumbophage PCH45 evades type I, but not type III, CRISPR-Cas immunity.

A type III-A CRISPR-Cas system employs degradosome nucleases to ensure robust immunity

Type III CRISPR–Cas provides resistance against nucleus-forming jumbo phages via abortive infection

Intracellular Organization by Jumbo Bacteriophages

Frontiers Biological and Molecular Characterization of a Jumbo Bacteriophage Infecting Plant Pathogenic Ralstonia solanacearum Species Complex Strains

A Jumbo Formation in the Viral Game Plan

A jumbo phage that forms a nucleus-like structure evades CRISPR–Cas DNA targeting but is vulnerable to type III RNA-based immunity

Degradation of Phage Transcripts by CRISPR-Associated RNases Enables Type III CRISPR-Cas Immunity: Cell

Jumbophage PCH45 evades type I, but not type III, CRISPR-Cas immunity.

Subcellular organization of viral particles during maturation of nucleus-forming jumbo phage

PDF) Spacer acquisition by Type III CRISPR-Cas system during bacteriophage infection of Thermus thermophilus

The jumbo phage is resistant to type I CRISPR-Cas immunity a. tblastx

A type III-A CRISPR-Cas system employs degradosome nucleases to ensure robust immunity

A jumbo phage that forms a nucleus-like structure evades CRISPR–Cas DNA targeting but is vulnerable to type III RNA-based immunity